GenMont Biotech Incorporation
GenMont Biotech Incorporation
Share · TW0003164000 (XTAI)
Overview
No Price
Closing Price XTAI 05.12.2025: 18,45 TWD
05.12.2025 05:24
Current Prices from GenMont Biotech Incorporation
ExchangeTickerCurrencyLast TradePriceDaily Change
XTAI: TWSE
TWSE
3164.TW
TWD
05.12.2025 05:24
18,45 TWD
0,05 TWD
+0,27 %
Share Float & Liquidity
Free Float 93,07 %
Shares Float 80,05 M
Shares Outstanding 86,01 M
Company Profile for GenMont Biotech Incorporation Share
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.
Get up to date insights from finAgent about GenMont Biotech Incorporation

Company Data

Name GenMont Biotech Incorporation
Company GenMont Biotech Incorporation
Website https://www.genmont.com.tw
Primary Exchange XTAI TWSE
ISIN TW0003164000
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Yu Chin Chen
Market Capitalization 2 Mrd.
Country Taiwan
Currency TWD
Employees 0,1 T
Address No.8, Nanke 7th Road, 741 Tainan City
IPO Date 2008-09-19

Ticker Symbols

Name Symbol
TWSE 3164.TW
More Shares
Investors who hold GenMont Biotech Incorporation also have the following shares in their portfolio:
E.ON SE MTN 23/28
E.ON SE MTN 23/28 Bond
VECTRON SYSTEMS
VECTRON SYSTEMS Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025